Unity Biotechnology, Inc.
NASDAQ:UBX
1.44 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -39.86 | -59.927 | -60.725 | -93.844 | -82.177 | -76.398 | -44.656 | -30.404 |
| Depreciation & Amortization
| 1.182 | 2.18 | 2.88 | 3.449 | 2.663 | 2.18 | 1.304 | 0.153 |
| Deferred Income Tax
| -10.193 | 0 | 0.92 | 2.383 | -6.933 | -1.515 | -0.408 | 8.974 |
| Stock Based Compensation
| 7.419 | 9.379 | 11.553 | 13.813 | 10.852 | 9.441 | 3.034 | 0.224 |
| Change In Working Capital
| -4.391 | -1.022 | -0.631 | -4.554 | 3.561 | 5.127 | 2.324 | 1.985 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 1.382 | -1.382 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.41 | -0.194 | -0.573 | -2.64 | -0.227 | 2.228 | 1.198 | 0.198 |
| Other Working Capital
| -3.981 | -0.828 | -0.058 | -1.914 | 3.788 | 2.899 | 1.126 | 1.787 |
| Other Non Cash Items
| 7.192 | -1.639 | 0.943 | 0.42 | -0.387 | 4.542 | 0.044 | 2.67 |
| Operating Cash Flow
| -38.651 | -51.029 | -45.06 | -78.333 | -72.421 | -56.623 | -38.358 | -16.398 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -0.011 | -0.096 | -0.195 | -0.646 | -1.586 | -1.264 | -1.689 | -2.244 |
| Acquisitions Net
| 0.115 | 0.378 | -39.508 | 4.562 | -69.539 | 0 | 0 | 0 |
| Purchases Of Investments
| -28.609 | -98.827 | -81.492 | -138.486 | -119.27 | -204.586 | -134.465 | -0.5 |
| Sales Maturities Of Investments
| 89 | 74 | 121 | 133.924 | 188.809 | 133.644 | 49.849 | 0 |
| Other Investing Activites
| 60.506 | -24.449 | 39.508 | -4.562 | 69.539 | -70.942 | -84.616 | -0.5 |
| Investing Cash Flow
| 60.495 | -24.545 | 39.313 | -5.208 | 67.953 | -72.206 | -86.305 | -2.744 |
| Financing Activities: | ||||||||
| Debt Repayment
| -20 | -0.003 | -0.068 | -0.405 | -0.073 | -0.074 | -0.055 | -16.887 |
| Common Stock Issued
| 5.223 | 54.713 | 18.572 | 37.27 | 26.085 | 136.109 | 42.83 | 107.938 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0.027 | 0.4 | -0.037 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -1.563 | 0.145 | 2.341 | 27.01 | 1.426 | 137.004 | 42.867 | 107.938 |
| Financing Cash Flow
| -14.777 | 54.855 | 20.845 | 63.875 | 27.438 | 136.93 | 42.775 | 107.938 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 7.067 | -20.719 | 15.098 | -19.666 | 22.97 | 8.101 | -81.888 | 88.796 |
| Cash At End Of Period
| 19.803 | 13.632 | 34.351 | 19.253 | 38.919 | 15.949 | 7.848 | 89.736 |